- Home
- CDTX vs MCFT Comparison
CDTX vs MCFT Comparison
Compare CDTX & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- MCFT
- Stock Information
- Founded
- CDTX 2012
- MCFT 1968
- Country
- CDTX United States
- MCFT United States
- Employees
- CDTX N/A
- MCFT N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- MCFT Marine Transportation
- Sector
- CDTX Health Care
- MCFT Industrials
- Exchange
- CDTX Nasdaq
- MCFT Nasdaq
- Market Cap
- CDTX 333.3M
- MCFT 298.7M
- IPO Year
- CDTX 2015
- MCFT 2015
- Fundamental
- Price
- CDTX $49.11
- MCFT $18.67
- Analyst Decision
- CDTX Strong Buy
- MCFT Buy
- Analyst Count
- CDTX 11
- MCFT 6
- Target Price
- CDTX $52.11
- MCFT $20.00
- AVG Volume (30 Days)
- CDTX 1.2M
- MCFT 114.2K
- Earning Date
- CDTX 08-12-2025
- MCFT 05-07-2025
- Dividend Yield
- CDTX N/A
- MCFT N/A
- EPS Growth
- CDTX N/A
- MCFT N/A
- EPS
- CDTX N/A
- MCFT N/A
- Revenue
- CDTX $302,000.00
- MCFT $303,243,000.00
- Revenue This Year
- CDTX N/A
- MCFT N/A
- Revenue Next Year
- CDTX N/A
- MCFT $16.03
- P/E Ratio
- CDTX N/A
- MCFT N/A
- Revenue Growth
- CDTX N/A
- MCFT N/A
- 52 Week Low
- CDTX $10.14
- MCFT $14.39
- 52 Week High
- CDTX $56.83
- MCFT $23.00
- Technical
- Relative Strength Index (RSI)
- CDTX 82.48
- MCFT 54.57
- Support Level
- CDTX $43.00
- MCFT $17.63
- Resistance Level
- CDTX $51.46
- MCFT $18.58
- Average True Range (ATR)
- CDTX 3.70
- MCFT 0.62
- MACD
- CDTX 2.89
- MCFT -0.03
- Stochastic Oscillator
- CDTX 79.88
- MCFT 41.95
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About MCFT MasterCraft Boat Holdings Inc.
MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.